The initiative's mission is to help solve some of the world's toughest challenges with an emphasis on supporting new scientific approaches to study human health and disease. The Codex platform allows researchers to catalogue cellular phenotypes within a tissue sample while maintaining their spatial context. The new method, called spatial phenotyping, facilitates analysis of how cells organize and interact to influence disease progression and treatment outcomes, according to Akoya.

The technology will be offered under favorable commercial terms to the Chan Zuckerberg Initiative grantee network, consisting of over 350 labs. Financial terms were not disclosed.

A human skin tissue sample shows the spatial interactions of immune cells and skin epidermal cells in a psoriasis rash. Immune cells (in yellow) are seen clustering beneath the epidermis as part of the local immune response. The tissue was stained with a 23-marker Codex panel to visualize epithelial and vascular markers and to survey the immune landscape of skin inflammation related to psoriasis. Image courtesy of Akoya.

Akoya posts positive results in Q1
Spatial biology tools company Akoya Biosciences reported growth in revenues and gross profits for the first quarter of 2021.

Pluristyx supports Kiadis' COVID-19 NK cell therapy
Pluristyx will be supporting Kiadis Pharma and the Advanced Regenerative Manufacturing Institute's BioFabUSA program by providing services for the research...